Vasoprotective effects of human CD34+ cells: towards clinical applications

BACKGROUND: The development of cell-based therapeutics for humans requires preclinical testing in animal models. The use of autologous animal products fails to address the efficacy of similar products derived from humans. We used a novel immunodeficient rat carotid injury model in order to determine...

Descripción completa

Detalles Bibliográficos
Autores principales: Kiernan, Thomas J, Boilson, Barry A, Witt, Tyra A, Dietz, Allan B, Lerman, Amir, Simari, Robert D
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2724497/
https://www.ncbi.nlm.nih.gov/pubmed/19640275
http://dx.doi.org/10.1186/1479-5876-7-66

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2724497/
https://www.ncbi.nlm.nih.gov/pubmed/19640275
http://dx.doi.org/10.1186/1479-5876-7-66

Ejemplares similares